Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Polycationic glycosides.
Engel R, Ghani I, Montenegro D, Thomas M, Klaritch-Vrana B, Castaño A, Friedman L, Leb J, Rothman L, Lee H, Capodiferro C, Ambinder D, Cere E, Awad C, Sheikh F, Rizzo J, Nesbitt LM, Testani E, Melkonian K. Engel R, et al. Among authors: cere e. Molecules. 2011 Feb 11;16(2):1508-18. doi: 10.3390/molecules16021508. Molecules. 2011. PMID: 21317841 Free PMC article.
Polycations. 17. Synthesis and properties of polycationic derivatives of carbohydrates.
Thomas M, Montenegro D, Castaño A, Friedman L, Leb J, Huang ML, Rothman L, Lee H, Capodiferro C, Ambinder D, Cere E, Galante J, Rizzo J, Melkonian K, Engel R. Thomas M, et al. Among authors: cere e. Carbohydr Res. 2009 Sep 8;344(13):1620-7. doi: 10.1016/j.carres.2009.04.021. Epub 2009 Apr 24. Carbohydr Res. 2009. PMID: 19467534
The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs.
Cosmi B, Legnani C, Pengo V, Ghirarduzzi A, Testa S, Poli D, Prisco D, Tripodi A, Palareti G; PROLONG Investigators (on behalf of FCSA, Italian Federation of Anticoagulation Clinics). Cosmi B, et al. Thromb Haemost. 2013 Mar;109(3):510-6. doi: 10.1160/TH12-01-0041. Epub 2013 Jan 10. Thromb Haemost. 2013. PMID: 23306310 Clinical Trial.
Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study.
Cosmi B, Legnani C, Tosetto A, Pengo V, Ghirarduzzi A, Testa S, Prisco D, Poli D, Tripodi A, Palareti G; PROLONG Investigators; FCSA, Italian Federation of Anticoagulation Clinics. Cosmi B, et al. Thromb Haemost. 2010 Jun;103(6):1152-60. doi: 10.1160/TH09-11-0759. Epub 2010 Mar 29. Thromb Haemost. 2010. PMID: 20352167 Clinical Trial.
Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.
Cosmi B, Legnani C, Iorio A, Pengo V, Ghirarduzzi A, Testa S, Poli D, Tripodi A, Palareti G; PROLONG Investigators (on behalf of FCSA, Italian Federation of Anticoagulation Clinics). Cosmi B, et al. Eur J Vasc Endovasc Surg. 2010 Mar;39(3):356-65. doi: 10.1016/j.ejvs.2009.11.022. Epub 2010 Jan 19. Eur J Vasc Endovasc Surg. 2010. PMID: 20034816 Free article. Clinical Trial.
D-dimer testing to determine the duration of anticoagulation therapy.
Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, Pengo V, Ghirarduzzi A, Pattacini C, Testa S, Lensing AW, Tripodi A; PROLONG Investigators. Palareti G, et al. N Engl J Med. 2006 Oct 26;355(17):1780-9. doi: 10.1056/NEJMoa054444. N Engl J Med. 2006. PMID: 17065639 Free article. Clinical Trial.
15 results